Actively Recruiting
Ravulizumab Treatment Outcomes in Patients With Generalized Myasthenia Gravis
Led by AstraZeneca · Updated on 2026-04-17
50
Participants Needed
14
Research Sites
241 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The Polish multicentre observational (non-interventional) study aiming to collect data on the management and clinical outcomes of patients with gMG that received ravulizumab.
CONDITIONS
Official Title
Ravulizumab Treatment Outcomes in Patients With Generalized Myasthenia Gravis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 years or older with generalized Myasthenia Gravis who have not received complement inhibitors and are treated with ravulizumab through the National Drug Program in Poland
- Patients willing to participate and who have signed an informed consent form
- Vaccination against Neisseria meningitidis
You will not qualify if you...
- Planning to participate in any generalized Myasthenia Gravis clinical trial on or after starting ravulizumab treatment through the National Drug Program
- Cognitive incapacity, unwillingness, or language barriers that prevent proper understanding or cooperation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 14 locations
1
Research Site
Bydgoszcz, Poland
Actively Recruiting
2
Research Site
Gdansk, Poland
Actively Recruiting
3
Research Site
Katowice, Poland
Actively Recruiting
4
Research Site
Katowice, Poland
Not Yet Recruiting
5
Research Site
Krakow, Poland
Actively Recruiting
6
Research Site
Lodz, Poland
Actively Recruiting
7
Research Site
Lublin, Poland
Actively Recruiting
8
Research Site
Poznan, Poland
Withdrawn
9
Research Site
Poznan, Poland
Not Yet Recruiting
10
Research Site
Szczecin, Poland
Actively Recruiting
11
Research Site
Szczecin, Poland
Not Yet Recruiting
12
Research Site
Warsaw, Poland
Actively Recruiting
13
Research Site
Warsaw, Poland
Not Yet Recruiting
14
Research Site
Wroclaw, Poland
Actively Recruiting
Research Team
A
AstraZeneca Clinical Study Information Center
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here